๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer

โœ Scribed by Sarah H. Taylor; Kelly W. Merriman; Philippe E. Spiess; Louis Pisters

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
107 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A new American Joint Committee on Cancer
A new American Joint Committee on Cancer staging system for cutaneous melanoma
โœ Charles M. Balch; Antonio C. Buzaid; Michael B. Atkins; Natale Cascinelli; Danie ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 2 views

O ver the past 2 decades, the principal clinical and pathologic fea- tures of melanoma that predict the risk of metastasis and survival rates have been delineated. The dominant independent prognostic factors involving melanoma patients treated throughout the world 1484

Outcome evaluation of the 1997 American
Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy
โœ Rajesh V. Iyer; Alexandra L. Hanlon; Wayne H. Pinover; Gerald E. Hanks ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

## BACKGROUND. The 1997 American Joint Committee on Cancer (AJCC) staging system condensed unilobular tumors into one entity and continues the use of both imaging and biopsy to alter classification status in T2 and T3 carcinomas. This study analyzes the biochemical freedom from disease recurrence

The National Cancer Data Base report on
The National Cancer Data Base report on completeness of American Joint Committee on Cancer staging in United States cancer facilities
โœ Irvin D. Fleming; Jerri Linn Phillips; Herman R. Menck ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 597 KB

BACKGROUND. American Joint Committee on Cancer [AJCC) staging is increasingly accepted as a prognostic standard for cancer management. The Commission on Cancer requires approved cancer programs to use AJCC staging for all cancers. Previous studies document increasing use of AJCC staging by hospitals